Literature DB >> 17931110

Immunological characterization of respiratory syncytial virus N protein epitopes recognized by human cytotoxic T lymphocytes.

Chiara Terrosi1, Giuseppa Di Genova, Gianni Gori Savellini, Pierpaolo Correale, Patrizia Blardi, Maria G Cusi.   

Abstract

Virus-specific cytotoxic T lymphocytes (CTLs) are crucial for the control of respiratory syncytial virus (RSV) infection. This study has identified CTL epitopes of the RSV N protein in healthy subjects. We screened the primary structure of the N protein for HLA-A 0201-binding amino acid consensus motifs, identifying three peptides designated as N-RSV1, N-RSV2, and N-RSV3. These peptides were used to generate CTL lines by stimulating human HLA-A 02.01 peripheral blood mononuclear cells (PBMCs) in vitro. These CTL lines were then characterized by performing CTL chromium release assays and IFN-gamma secretion detection by intracellular cytokine staining. N-RSV1 and N-RSV3 peptides elicited the strongest cytolytic activity against RSV-infected cells and they could be useful epitopes for the analysis of CTL responses to RSV and for understanding immune-induced disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17931110     DOI: 10.1089/vim.2007.0041

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  8 in total

1.  Serologic cross-reactions between nucleocapsid proteins of human respiratory syncytial virus and human metapneumovirus.

Authors:  Yange Zhang; Jan Pohl; W Abdullah Brooks; Dean D Erdman
Journal:  J Clin Microbiol       Date:  2015-03-04       Impact factor: 5.948

2.  Enhancement of the CD8+ T cell response to a subdominant epitope of respiratory syncytial virus by deletion of an immunodominant epitope.

Authors:  Hoyin Mok; Sujin Lee; David W Wright; James E Crowe
Journal:  Vaccine       Date:  2008-07-26       Impact factor: 3.641

3.  Multiple, non-conserved, internal viral ligands naturally presented by HLA-B27 in human respiratory syncytial virus-infected cells.

Authors:  Susana Infantes; Elena Lorente; Eilon Barnea; Ilan Beer; Juan José Cragnolini; Ruth García; Fátima Lasala; Mercedes Jiménez; Arie Admon; Daniel López
Journal:  Mol Cell Proteomics       Date:  2010-01-15       Impact factor: 5.911

4.  Age related changes in T cell mediated immune response and effector memory to Respiratory Syncytial Virus (RSV) in healthy subjects.

Authors:  Maria Grazia Cusi; Barbara Martorelli; Giuseppa Di Genova; Chiara Terrosi; Giuseppe Campoccia; Pierpaolo Correale
Journal:  Immun Ageing       Date:  2010-10-20       Impact factor: 6.400

5.  Immunoprotectivity of HLA-A2 CTL peptides derived from respiratory syncytial virus fusion protein in HLA-A2 transgenic mouse.

Authors:  Hsiao-Yun Shao; Yi-Wen Lin; Shu-Ling Yu; Hsiang-Yin Lin; Ebenezer Chitra; Yung-Chen Chang; Charles Sia; Pele Chong; Ming-Tao Hsu; Olivia L Wei; Yen-Hung Chow
Journal:  PLoS One       Date:  2011-09-29       Impact factor: 3.240

6.  In silico analysis of amino acid variation in human respiratory syncytial virus: insights into immunodiagnostics.

Authors:  Claudemir Souza; Nilson It Zanchin; Marco A Krieger; Adriana Ludwig
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-10       Impact factor: 2.743

7.  Gene optimization leads to robust expression of human respiratory syncytial virus nucleoprotein and phosphoprotein in human cells and induction of humoral immunity in mice.

Authors:  Fernando M Simabuco; Rodrigo E Tamura; Cassiano Carromeu; Luis E Farinha-Arcieri; Armando M Ventura
Journal:  J Virol Methods       Date:  2009-02-04       Impact factor: 2.014

Review 8.  Innate Immune Components that Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections.

Authors:  Catalina A Andrade; Gaspar A Pacheco; Nicolas M S Gálvez; Jorge A Soto; Susan M Bueno; Alexis M Kalergis
Journal:  Viruses       Date:  2020-06-12       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.